Drugs / Amoxicillin/clavulanate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06229288 Comparator | Apr 2024 → May 2027 expected | pneumonia | Nantes University Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amoxicillin/clavulanate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06229288 ↗ |
| Route | Intravenous | “Participants will be randomized to IV/oral amoxicillin or IV/oral amoxicillin/clavulanate for 5 days.” NCT06229288 ↗ |
| Route | Oral | “Participants will be randomized to IV/oral amoxicillin or IV/oral amoxicillin/clavulanate for 5 days.” NCT06229288 ↗ |